-The Business Standard Agri Survey diagnoses the key problems correctly The first-ever Agricultural Survey tabled in Parliament, emulating the presentation of the Economic Survey, seems a well-meaning exercise in candid analysis of the factors that have constrained the sector’s growth. Being an inaugural report card, it has done well not to confine itself to developments during 2011-12. The long-term trends do, indeed, provide the answers to some of the key questions...

Often, municipal corporations carry out flawed projects which go against public interest and only suit vested interests. Use of RTI can help unearth such irregularities. Here’s a startling example... The Mula-Mutha rivers in Pune resemble stinking nallahs, yet the Pune Municipal Corporation (PMC) had a brainwave of implementing a river navigation project on a 25-odd km stretch from Ramwadi to Kharadi, envisioning boat rides as one of the activities to save...

-The Hindu Business Line A Government report has called for enhancing investment in agriculture and leveraging technology to boost the country's farm sector growth in the years ahead. The report ‘State of Indian Agriculture 2011-12,' released by the Agriculture Ministry on Tuesday, called for institutional reforms in research set up to make it more accountable and geared towards delivery, conservation of natural resources such as water and land among others. “Achieving a 8-9...

-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

-The Economic Times The government has allowed a local drugmaker to make and sell a patented cancer drug at a fraction of the price charged by Germany's Bayer AG, setting a precedent for more such efforts by Indian firms and heightening the global pharmaceutical industry's anxiety over the use of the controversial compulsory licensing provision.  The outgoing patent controller of India, PH Kurian, on Monday granted the country's first compulsory licence to...